MilliporeSigma Reinforces Biotech Leadership in Temecula with New Investments and Community Engagement

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has deepened its roots in Temecula, California, since establishing operations there in 1989. Over the decades, the site has evolved into a major center for advanced biomedical and biotechnical manufacturing, playing a critical role in global research efforts. The company's recent investments, including the acquisition of HUB Organoids and the opening of a new organoid development lab, position Temecula at the forefront of cutting-edge science. These facilities focus on developing patient-derived organoid models for disease modeling, drug screening, and personalized medicine, offering researchers powerful tools to study diseases and test therapies more accurately than traditional methods.

MilliporeSigma's Temecula site is integral to the company's work in antibody development, stem cell technologies, and other life science tools used by researchers worldwide. The expansion underscores the company's commitment to innovation and its ability to adapt to the evolving needs of the biotechnology sector. By investing in organoid technology, MilliporeSigma is helping to reduce reliance on animal testing and improve the predictability of drug candidates, which could accelerate the development of new treatments for conditions such as cancer, neurodegenerative disorders, and rare genetic diseases.

Beyond its scientific contributions, MilliporeSigma has become a pillar of the Temecula community. The company actively supports local education through STEM programs, partners with nonprofit organizations, and participates in community initiatives like food drives. This long-term commitment demonstrates that MilliporeSigma views its role in Temecula as more than just an employer—it seeks to be a responsible corporate citizen that contributes to the region's quality of life and economic vitality.

The Southern California Wine Country Economic Development Corporation (EDC), a nonprofit that serves Temecula and surrounding cities, highlighted MilliporeSigma's impact as a model for how businesses can drive both economic growth and community well-being. For more than 30 years, the EDC has helped businesses relocate, expand, or start up in one of Southern California's fastest-growing regions by leveraging partnerships, incentives, and a business-friendly environment. The EDC's mission aligns with MilliporeSigma's approach, as the company's sustained investment in Temecula reinforces the area's reputation as a strategic location for biotechnology and life sciences.

As MilliporeSigma continues to build on its legacy, the Temecula site is poised to remain a key contributor to global health advancements. The combination of state-of-the-art facilities, a skilled workforce, and a supportive community positions the company to tackle some of the most pressing challenges in medicine and biology. With the new organoid lab and ongoing expansions, MilliporeSigma is not only advancing science but also solidifying Temecula's place on the map as a hub for biotechnological innovation.